Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Teijin discloses PDGF-inhibitory agents

Nov. 8, 1996

Teva generic drug licensed by FDA

Nov. 8, 1996

Nycomed discontinues development of antihypertensive drug

Nov. 8, 1996

Natural dual inhibitor of ECE and NEP described by Sankyo

Nov. 8, 1996

Potential antihypertensive agents reported by Kyowa Hakko

Nov. 8, 1996

cGMP-PDE inhibitors described by Sanofi Winthrop

Nov. 1, 1996

Antiarrhythmic 1,4-benzodiazepine from Merck

Nov. 1, 1996

Safer antiarrhythmic agent reported by Canadian researchers

Nov. 1, 1996

Hoechst claims new antiarrhythmic agents

Nov. 1, 1996

Atlantic's CT-1 and CT-2 prevent restenosis

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...